We have reported that i.v. administration of splenocytes prepared from early pregnant mice promoted embryo implantation in pseudopregnant CD-1 (ICR) (closed colony) mice. In this study, the similar effects of splenocytes were confirmed using an inbred strain, BALB/c mice, and the mechanism was further investigated. Splenocytes were prepared from pregnancy day 4 (P4-spl) and dioestrus mice (Di-spl), and supernatant of P4-spl suspension (P4-sup) was used as controls. On pseudopregnancy day 2, splenocytes or supernatant were injected into caudal vein or endometrial stroma of the recipient mice, and blastocysts were transferred into the endometrial lumen. In both BALB/c and ICR strains, the implantation rates per recipient with i.v. and intraendometrial injection were significantly higher in P4-spl groups. Then, ICR mice were oophorectomized on pseudopregnancy day 3. After 3 day progesterone supplementation, blastocysts were transferred with i.v. injection of P4-spl and P4-sup, or s.c. oestradiol injection. Under progesterone supplementation, successful implantations were observed in the P4-spl-and oestradioltreated groups, but not in P4-sup-treated group. Reverse transcriptase-polymerase chain reaction analysis revealed that messenger RNA expression of leukaemia inhibitory factor in the uterus was induced by P4-spl and oestradiol, but not by P4-sup. These findings showed that splenocytes of early pregnant mice promote embryo implantation by regulating endometrial differentiation.
Introduction
The synchronization of embryo development and uterine preparation is necessary for successful implantation (Beier et al., 1970 (Beier et al., , 1989 . During this process, the ovarian steroid hormones play a major role in creating a receptive phase by 2102 © European Society for Human Reproduction and Embryology regulating cyclic morphological changes of the endometrium (Psychoyos, 1973 (Psychoyos, , 1993 . The endometrium is also immunologically significant because the semi-allogeneic embryo/fetus is normally not rejected by the mother. Endometrial stromal cells and endometrial lymphocytes constitute the maternal aspect of the materno-fetal interface and are considered to contribute to successful pregnancy (Kearns and Lala, 1983; Bulmer, 1996) . Recently, many cytokines have been reported to be present in the endometrium (Tabibzadeh, 1991) , and some of them are proposed to regulate endometrial differentiation and blastocyst implantation in an autocrine and/or paracrine fashion (Kariya et al., 1991; Irwin et al., 1991; Simón et al., 1996) .
We demonstrated that human luteal cells in ovarian corpus luteum of early pregnancy express human leukocyte antigen-DR and leukocyte functional antigen-3, suggesting the interaction between lymphocytes and luteal cells during early pregnancy (Fujiwara et al., 1993; Hattori et al., 1995) . We speculated that immune cells in early pregnancy possess information on the presence of an embryo, transmit it to the corpus luteum and regulate corpus luteum differentiation (Hattori et al., 1995) .
Therefore, to clarify the role of immune cells in the reproductive process during early pregnancy, we examined the effect of splenocytes obtained from early pregnant mice on embryo implantation. Intra-venous administration of splenocytes obtained from early pregnancy was found to enhance implantation rates in the female ICR mice which received embryo transfer on pseudopregnancy day 2. This effect was more prominent in the splenocytes from pregnancy day 4 than in those from pregnancy day 8, pseudopregnancy day 4 and dioestrus day 2 mice (Takabatake et al., 1997) . In this study, we further examined this phenomenon to determine whether pregnant splenocytes directly regulate endometrial differentiation or not. chorionic gonadotrophin (HCG) were purchased from Teikoku Zoki Co. (Tokyo, Japan).
Splenocyte transfusion and embryo transfer into pseudopregnant mice
The splenocytes were obtained from 9-week-old pregnant BALB/c mice on pregnancy day 4 (P4-spl), which were mated after stimulation by PMSG (5 IU) and HCG (5 IU), and 9-week-old virgin female BALB/c mice on dioestrus day 2 (Di-spl). To reduce contamination of red cells, the mouse was exsanguinated from the retro-orbital plexus under ether anaesthesia and then killed by cervical dislocation. Laparotomy was performed, and the spleen was carefully removed. The spleen was placed on Petri dishes and cut in several places. The pieces were pressed by scissors until mostly fibrous tissue remained. After filtration through nylon mesh, splenocytes were washed four times and suspended in PBS at a concentration of 1ϫ10 8 cells/ml. Supernatant (P4-sup) obtained from the final suspension of P4-spl was also prepared. Blastocysts were recovered from donor pregnant BALB/c mice (pregnancy day 4), which were 9 weeks old and had been mated after stimulation by PMSG (5 IU) and HCG (5 IU). The 10-week-old pseudopregnant recipient BALB/c mice were prepared by mating with vasectomized males. At 1500 h on pseudopregnancy day 2, the recipient mice were injected with a 200 µl cell suspension of P4-spl or Di-spl or with 200 µl of P4-sup through the caudal vein. Five embryos per uterus were transferred into each uterine cavity of recipient mice under anaesthesia by nembutal 1 h after the splenocyte transfusion. As a control, embryos were transferred into uterine cavities of pseudopregnant mice without i.v. injection. For each group, five recipients were used, and the experiments were repeated six times. Seven days after the embryo transfer, laparotomy was performed, and embryo implantation was evaluated ( Figure 1A ).
Intraendometrial administration of splenocytes and intraluminal embryo transfer into pseudopregnant mice
In BALB/c mice, pseudopregnant recipient mice, P4-spl, P4-sup and blastocysts were prepared as described above. In ICR mice, 6-weekold recipient pseudopregnant mice were prepared by mating with vasectomized males, splenocytes were prepared from 5-week-old pregnant (day 4) and virgin (dioestrus day 2) mice. Blastocysts were recovered from donor pregnant mice (pregnancy day 4), which were 5 weeks old and had been mated after stimulation by PMSG (5 IU) and HCG (5 IU). At 1600 h on pseudopregnancy day 2, 1 µl of P4-spl suspended in PBS (1ϫ10 4 cells/µl) was gently injected into the unilateral endometrial stroma along the uterine long axis using a fine micropipette after parallel insertion of a 27 G injection needle as described previously (Goto et al., 1992) . P4-sup (1 µl) was injected into the contralateral endometrial stroma as a control. Immediately after the intraendometrial injection, five embryos per uterus were transferred into each luminal cavity of the uteri.
In ICR mice, P4-spl were further divided into the monocyte-rich and T-lymphocyte-rich populations. Monocyte-rich cell suspension was prepared from P4-spl by a macrophage separating plate kit (MSP kit; Japan Immunoresearch Lab. Co. Ltd., Takasaki, Japan). Freshly isolated P4-spl were washed by PBS, overlayered on a lymphocyte separating reagent (Lympholyte M; Cedarlane Lab. Ltd, Hornby, Canada) and centrifuged at 1000 g. Mononuclear cells were isolated from the interphase layer, washed by PBS twice and suspended in Dulbecco's minimum essential medium (Nissui Pharmaceutical Co., Ltd, Tokyo, Japan) supplemented with 5% fetal calf serum (Grand Island Biological Co., Grand Island, NY) at the concentration of 3ϫ10 6 cells/ml. Of each cell suspension, 3 ml was placed on the MSP dish and incubated for 1 h at 37°C. After the incubation, the plates were gently washed three times to remove unattached cells, T-lymphocyte-rich cell suspension was prepared from P4-spl by a cellect™ mouse T cell kit (Biotex Lab. Inc., Alberta, Canada) according to the manual's instructions. Briefly, unattached cells after incubation of isolated mononuclear cells on MSP dishes were collected and applied to activated cellect™ mouse T cell column, which separated T-lymphocytes from B-lymphocytes by negative selection. The eluted cells that passed through the column were washed by PBS and resuspended in PBS at the concentration of 1ϫ10 4 cells/µl.
The cell viability of both monocyte-rich cell suspension and Tlymphocyte-rich cell suspension examined by trypan blue exclusion was Ͼ90%. Intraendometrial administration of monocyte-rich or T-lymphocyte-rich cell suspension and each control supernatant were performed as described above. Immediately after the intraendometrial injection, five embryos per uterus were transferred into each luminal cavity of the uteri.
In each experiment, five recipients were used, and the experiments were repeated six times. The implantation sites were evaluated 7 days after embryo transfer ( Figure 1B ).
Embryo transfer into ovariectomized pseudopregnant mice with supplementation of progesterone under the treatment of 17β-oestradiol or splenocytes P4-spl and blastocysts were prepared as described above. To induce and maintain delayed implantation, pseudopregnant ICR mice (6-week-old) were ovariectomized in the afternoon of pseudopregnancy day 3 and received daily injections of progesterone (2 mg/mouse) from day 4 to day 7 as described with minor modification (Hogan et al., 1994; Dey, 1996) . On pseudopregnancy days 7 and 8, the recipients were injected i.v. with P4-spl in PBS (2ϫ10 7 /200 µl) or P4-sup (200 µl), or were injected s.c. with 17β-oestradiol (25ng/body) at 1500 h. The 5 blastocysts per uterus were transferred to the treated recipient mice at 1600 h on pseudopregnancy day 7. In each group, 5 recipients were used, and the experiments were repeated six times. The daily supplementation of progesterone was further continued and the implantation rate was evaluated 7 days after embryo transfer ( Figure 1C ).
To examine the effect of 17β-oestradiol and splenocytes on the expression of leukaemia inhibitory factor (LIF) messenger RNA (mRNA), the oophorectomized pseudopregnant ICR mice followed by progesterone supplementation were killed 12 h or 24 h after single injection of P4-spl, P4-sup or 17β-oestradiol on pseudopregnancy day 7, and the uteri were immediately removed and frozen in liquid nitrogen for reverse transcriptase-polymerase chain reaction (RT-PCR) analysis ( Figure 1D ).
RNA isolation
To examine the expression profile of uterine LIF mRNA levels throughout pseudopregnancy, ICR mice on pseudopregnancy days 1-6 were killed between 0830 and 0900 h. The obtained uterine samples were immediately frozen in liquid nitrogen and stored at Ϫ80°C until RNA extraction. Total RNAs of uterine tissues from the pseudopregnant mice and the oophorectomized pseudopregnant mice in a delayed implantation model were isolated using a commercial kit (TRIzol; Gibco BRL, Gaithersburg, MD, USA).
Isolation of murine LIF and β-actin complementary DNA (cDNA) clone Two micrograms of uterine total RNA from pregnant mice were reverse-transcribed with random primers by a commercial kit (First Strand cDNA Synthesis Kit; Pharmacia, Inc., Piscataway, NJ, USA). The resulting cDNA mixture was subjected to 30 cycles of PCR amplification with oligonucleotides from the murine LIF cDNA as primers (Gearing et al., 1988 ) (sense primer 5Ј-CCCATAATGAA-GGTCTTGGC-3Ј: position 10-29; antisense primer 5Ј-CTCCTCAC-TAGAATGCCTGGAC-3Ј: position 613-634) or with murine β-actin primers (Tokunaga et al., 1986 ) (sense primer 5Ј-TCAGAAGGAC-TCCTATGTGG-3Ј: position 224-243; antisense primer 5Ј-TCT-CTTTGATGTCACGCACG-3Ј: position 704-723). The PCR product was cloned into a pBluescript SK(-) plasmid, and the insert was verified by sequencing (Higuchi et al., 1995) .
Northern blotting
Northern blotting was done as previously described (Higuchi et al., 1995) . Briefly, 20 µg of total RNA were electrophoresed on a 1.0% agarose-formaldehyde gel and then transferred to nylon membranes (Hybond-Nϩ; Amersham Corp., Arlington Heights, IL, USA). The membranes were hybridized with 32 P-labelled DNA probes in Rapid Hyb buffer (Amersham Corp.), following the manufacturer's protocol. The probe was labelled by random primer labelling (Megaprime,
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Amersham Corp.) to a specific radioactivity of 0.8-1.5ϫ10 9 c.p.m./ µg DNA. As a control for the amount of RNA loaded, the membrane was also probed with the constitutively expressed β-actin gene.
RT-PCR and Southern blot analysis
The first-strand cDNA were prepared from 5 µg of total cellular RNA from murine uterine samples as described above. The PCR solutions containing each cDNA mixture were made and then subjected to PCR amplification with primers for murine LIF. PCR amplification with murine LIF primers was carried out as described above. After PCR amplification, 16 µl from each PCR product was electrophoresed on a 1% agarose gel and transferred to a nylon membrane (Hybond Nϩ, Amersham). The membrane was hybridized with 32 P-labelled LIF probe under conditions as previously described (Church and Gilbert, 1984) . Each first strand cDNA mixture was also subjected to 25 cycles of PCR amplification with murine β-actin primers. Resulting PCR products were electrophoresed on a 1% agarose gel, and amplified bands were detected by ethidium bromide staining.
Statistical analysis
Implantation rates per recipient or uterus (%) were calculated in each experiment and expressed as means Ϯ SD. In i.v. administration, the differences of implantation rates per recipient between the splenocyteor supernatant-treated mice and controls were analysed by the Kruskal-Wallis test. In intraendometrial administration, the difference in the implantation rates per uterus between the splenocyte-treated and the supernatant-treated uteri was compared by the Mann-Whitney U-test. In the oophorectomized mice, the differences of implantation rate per recipient were analysed by the Kruskal-Wallis test. The difference was considered to be significant at P Ͻ 0.05.
Results

Implantation rates in pseudopregnant mice with systemic administration of splenocytes
In BALB/c mice, successful implantation was observed only in the P4-spl group (29 Ϯ 11.9%, P Ͻ 0.01). No implantation was observed in P4-sup, Di-spl or control groups.
Implantation rates in pseudopregnant mice with intraendometrial administration of splenocytes
In BALB/c mice, a significant increase of implantation rate per uterus was observed in the P4-spl-injected uteri (25 Ϯ 17.7%, P Ͻ 0.05). In contrast, no implantation was observed in the P4-sup-injected uteri (Figure 2) .
In ICR mice, implantation rate per uterus was significantly higher in the P4-spl group (60.0 Ϯ 18.1%) than that in the P4-sup group (21.7 Ϯ 21.7%, P Ͻ 0.05) (Figure 2 ). In the T-lymphocyte-rich preparation, a significant increase of implantation rate per uterus was also observed compared with controls (47.3 Ϯ 18.3% versus 15.7 Ϯ 15.1%, P Ͻ 0.05), while no significant increase of implantation rate per uterus was observed in the monocyte-rich preparation (16.4 Ϯ 13.6% versus 8.89 Ϯ 14.4%) (Figure 3 ).
The effect of the treatment of 17β-oestradiol or splenocytes on embryo transfer into ovariectomized pseudopregnant mice
Seven days after embryo transfer into ICR mice, successful implantation was observed in P4-spl-treated and oestradiol- Figure 2 . Implantation rates in BALB/c and ICR pseudopregnant mice with intraendometrial administration of P4-spl. On pseudopregnancy day 2, P4-spl (1ϫ10 4 cells) was injected into the endometrial stroma of the unilateral uterus, and P4-sup was injected into the contralateral endometrial stroma as a control. Immediately after the intraendometrial injection, five embryos per uterus were transferred into each luminal cavity of the uterus. In both strains, implantation rates per uterus were significantly higher in P4-spl groups than those in P4-sup groups. *P Ͻ 0.05. Figure 3 . Implantation rates in ICR pseudopregnant mice with intraendometrial administration of T-cell-rich P4-spl and monocyterich P4-spl. On pseudopregnancy day 2, T-cell-rich P4-spl or monocyte-rich P4-spl (1ϫ10 4 cells) was injected into the endometrial stroma of the unilateral uterus, and each supernatant of cell suspension was injected into the contralateral endometrial stroma as a control. In T-cell-rich P4-spl group, a significant increase of implantation rate per uterus was observed, while no significant increase was observed in monocyte-rich P4-spl group. treated groups (50.0 Ϯ 10.6% and 75.0 Ϯ 29.4% per recipient, respectively), but no implantation was observed in the P4-suptreated group (P Ͻ 0.01) (Figure 4) .
Northern blotting and RT-PCR analysis on the expression of mRNA of LIF in the uterus
In pseudopregnant murine uteri, distinct expression of LIF mRNA was observed on days 1 and 4 of pseudopregnancy as previously described in normal pregnant mice (Bhatt et al., 1991) (Figure 5 ). In the mice, in which the delay of implantation was experimentally prepared, the injection of splenocytes induced distinct expression of LIF mRNA after 12 and 24 h of injection ( Figure 6, lanes 2 and 5) . Sensitive RT-PCR Southern blotting could not detect LIF mRNA expression when the supernatant was injected instead of splenocytes Figure 4 . The effect of the treatment of 17β-oestradiol or splenocytes on embryo transfer into ovariectomized pseudopregnant mice. Pseudopregnant ICR mice were oophorectomized on pseudopregnancy day 3. After progesterone administration for 3 days, blastocysts were transferred into the uterine cavities with i.v. injection of P4-spl or P4-sup, or with s.c. oestradiol injection. Under progesterone supplementation, successful implantations were observed in P4-spl-and oestradiol-treated groups, but no implantation was observed in P4-sup-treated group. ( Figure 6 , lanes 3 and 6). As previously described, injection of oestradiol also induced LIF mRNA expression (Bhatt et al., 1991) (Figure 6, lanes 1 and 4) .
Discussion
In rodents, the uterus is in the receptive phase for only a few days, the so-called 'implantation window' (Psychoyos, 1993; Dey, 1996) . Previously, we demonstrated that systemic administration of splenocytes from early pregnant ICR mice changed the receptivity of the uterus on pseudopregnant day 2 (Takabatake et al., 1997). In ICR mice, P4-spl more effectively facilitated embryo implantation than splenocytes derived from pregnancy day 8, pseudopregnancy day 4 and dioestrus day 2 mice, suggesting that the presence of an embryo in the donor mice for splenocyte preparation is important for the effect of Figure 6 . Effects of systemically administered splenocytes on leukaemia inhibitory factor (LIF) mRNA expression in uteri of delayed implantation. Experimentally induced delay of implantation was achieved as described in the text, and oestradiol (lanes 1 and 4), P4-spl in PBS (lanes 2 and 5), or P4-sup (lanes 3 and 6) was administered i.v. on day 7 of pseudopregnancy. Whole uteri from these mice were collected after 12 (lanes 1-3) and 24 (lanes 4-6) h of administration, and first-strand cDNAs from these samples were subjected to reverse transcriptase-polymerase chain reaction (PCR) amplification with LIF primers. Resultant PCR products were separated by agarose gel electrophoresis, transferred to nylon membranes, and hybridized to LIF probe (upper panel). Each firststrand cDNA mixture was also subjected to PCR amplification with β-actin primers, and amplified bands were detected by ethidium bromide staining (lower panel). Expression of uterine LIF mRNA was evident by administration of splenocytes as well as oestradiol.
splenocytes on implantation (Takabatake et al., 1997) . Although ICR mice are a profitable strain for embryo transfer experiments, it is a closed colony. It is possible that nonspecific immune reaction for allograft is involved in the effect of spleen cell transfusion. Therefore, we used BALB/c mice, which is an inbred strain, and confirmed the same effects of splenocytes in early pregnancy on embryo implantation. This indicates that the increase of implantation rate by P4-spl is not caused by a non-specific immune reaction.
Since systemic administration of P4-sup showed no effect, cellular components of the spleen were considered to facilitate implantation. To prepare the endometrium for implantation, pre-implantation ovarian secretion of oestrogen and progesterone is considered important (Finn, 1966; Yoshinaga and Adams, 1966; Finn and Martin, 1970; Dey, 1996) . It was also reported that rat splenocytes increase the function of corpus luteum and secretion of progesterone (Saito et al., 1988) . Therefore, it is possible that systemically administered splenocytes firstly affect ovarian secretion of sex steroid hormones, and then these hormones accelerate the differentiation of endometrium and change the receptivity. Another explanation is that P4-spl facilitate implantation through the direct effects on endometrial function and/or differentiation. To examine the direct effects of P4-spl on the endometrium, we injected P4-spl into the endometrial stroma and observed the significant increase of successful implantation in both strains. Although transformation of the endometrium was demonstrated to be induced by experimental stimuli (Loeb, 1908; Fainstat, 1963) , the increase of receptivity for implantation by P4-spl was not a non-specific reaction because there were no differences in the methods of intraendometrial administration and embryo transfer between P4-spl and P4-sup groups. This finding strongly suggests the direct effect of P4-spl on the endometrium.
The population of immune cells in the endometrium changes according to oestrous cycle and pregnancy (Peel and Bulmer, 1977) . Many investigators reported that endometrium contains a variety of immune cells, such as granulated lymphocyte-like cells and macrophages, and speculated that they are important for implantation (Bulmer and Sunderland, 1984; Stewart, 1984; Parr et al., 1990; De et al., 1991; Bulmer, 1996) . In this study, intraendometrial administration of the T-lymphocyterich population from P4-spl increased the implantation rate, whereas the monocyte-rich preparation did not. We also observed that in ICR mice, systemic administration of thymocytes derived from immature female mice also increased implantation during the non-receptive phase (unpublished data). Presently, we speculate that T-lymphocytes, including immature ones, contribute to the increase of implantation observed in this study and that the effective T-lymphocytes can be obtained from the spleen when the mouse is pregnant.
For the direct effects of P4-spl on the endometrium, two pathways should be proposed. One is that P4-spl regulate endometrial differentiation, and in turn, endometrium reaches the receptive phase for implantation. The second is that P4-spl influence the immune balance between reception and rejection against embryos in the endometrium. To examine the effect of P4-spl on endometrial differentiation, we used a model of delayed implantation and examined the expression of mRNA of LIF which is reported to be indispensable for implantation in mice (Stewart et al., 1992) . As reported, successful implantation was observed in the group of oestradiol administration (Yoshinaga and Adams, 1966) , but no implantation was observed in the group of P4-sup injection. Under the same conditions, successful implantation was observed in the group of P4-spl administration in spite of no oestradiol supplementation. Similarly, P4-spl administration induced the expression of mRNA of LIF in the uterus, which was also observed with oestradiol administration as previously reported (Bhatt et al., 1991) . These findings suggest that the effects of P4-spl on implantation is independent of the ovary, and that P4-spl can regulate endometrial differentiation and facilitate embryo implantation. In addition, the mechanism of the promoting effect of P4-spl on embryo implantation resembles that of oestradiol.
In general, endometrial differentiation is considered to be systemically regulated by the endocrine system. In the uterus, embryo implantation is achieved under the influence of the interaction among embryo, endometrium, and immune cells. This study demonstrated that the immune system can regulate endometrial differentiation and embryo implantation, showing that endometrial differentiation and embryo implantation are carried out under the dual controls of the endocrine and immune systems. Since blastocysts have not yet implanted on pregnancy day 4 and P4-spl already have the promoting effects on endometrial differentiation and implantation, it is speculated that peripheral immune cells receive some signals from preimplanted embryos in the reproductive tract and then operate on the preparation for embryo implantation in the uterus.
Recently, implantation failure has been a focus of in-vitro fertilization and embryo transfer therapy, in which embryos of good quality failed to implant in the endometrium. Abnormal endometrial differentiation and/or immune responses are considered to cause implantation failure (Edwards, 1995) . At present, there is no effective therapy for when the endometrium cannot correctly react with the stimulation by sex steroid hormones, i.e. the endocrine system. In these cases, another approach should be tried from a different aspect, such as immune control. In this regard, intraendometrial administration of peripheral mononuclear cells can contribute to the treatment of implantation failure.
In conclusion, we demonstrated that splenocytes derived from early pregnant mice facilitate murine embryo implantation. These splenocytes regulated endometrial differentiation and made the endometrium a receptive phase for implantation. Investigation of the mechanism of these findings is needed and will contribute to the therapy for implantation failure.
